Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Labcorp HoldingsLTS:0JSY +2.59%80 EV-to-OCF is 16.88 as of Jul. 26, 2026, which is 13% above its 10-year median of 14.92. GuruFocus rates LTS:0JSY with a GF Score™ of 80/100 and a GF Value™ of $270.43 (Fairly Valued). The stock has 6 warning signs investors should review. Among 213 Medical Diagnostics & Research companies, Labcorp Holdings ranks worse than 70.42% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Labcorp Holdings's Enterprise Value is $30,612 Mil.
Labcorp Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $1,814 Mil. Therefore, Labcorp Holdings's EV-to-OCF for today is 16.88.
The historical rank and industry rank for Labcorp Holdings's EV-to-OCF or its related term are showing as below:
LTS:0JSY'
s EV-to-OCF Range Over the Past 10 Years
Min: 8.37 Med: 14.92 Max: 20.21
Current: 16.88
During the past 13 years, the highest EV-to-OCF of Labcorp Holdings was 20.21. The lowest was 8.37. And the median was 14.92.
LTS:0JSY's EV-to-OCF is ranked worse than 70.42% of 213
companies
in the Medical Diagnostics & Research industry
Industry Median: 6.08
vs LTS:0JSY: 16.88
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Labcorp Holdings's PE Ratio (TTM) for today is calculated as:
Labcorp Holdings's share price for today is $296.35.
Labcorp Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.290.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Labcorp Holdings EV-to-OCF Related Terms
Labcorp Holdings EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Labcorp Holdings's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Labcorp Holdings's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings EV-to-OCF vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's EV-to-OCF falls into.
Labcorp Holdings's current Enterprise Value is $30,612 Mil.
Labcorp Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,814 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labcorp Holdings (LTS:0JSY) has a EV-to-OCF of 16.88 as of Jul. 26, 2026. This is 13% above median its historical median of 14.92. Over the past decade, Labcorp Holdings' EV-to-OCF has ranged from 8.37 to 20.21. According to the industry distribution chart, Labcorp Holdings ranks #150 out of 213 companies in the Medical Diagnostics & Research industry, placing it in the top 70.4%.
Is Labcorp Holdings' EV-to-OCF too high?
Labcorp Holdings' current EV-to-OCF of 16.88 is 13% above median its 10-year median of 14.92. Over the past 10 years, this metric has ranged from a low of 8.37 to a high of 20.21. The Medical Diagnostics & Research industry median EV-to-OCF is 6.08. Labcorp Holdings' value of 16.88 is 177.6% above this industry median. Based on the distribution chart, Labcorp Holdings ranks #150 out of 213 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Labcorp Holdings has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' EV-to-OCF compare to DGX and GH?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #150 out of 213 companies for EV-to-OCF. This places Labcorp Holdings in the lower half of its industry. The industry median EV-to-OCF is 6.08. Labcorp Holdings' value of 16.88 is 177.6% above this benchmark. Historically, Labcorp Holdings' own EV-to-OCF has ranged from 8.37 to 20.21 over the past decade. While the company's 10-year median is 14.92 vs. the industry median of 6.08, Labcorp Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Diagnostics & Research company?
The median EV-to-OCF among Medical Diagnostics & Research companies is 6.08, based on 213 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labcorp Holdings's current EV-to-OCF of 16.88 is 177.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Diagnostics & Research industry, the median EV-to-OCF is 6.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labcorp Holdings's current EV-to-OCF is 16.88, which is 13% above median its own 10-year median of 14.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $270.43, compared to a current price of $296.35 — trading 9.6% above its estimated fair value. The current EV-to-OCF is 16.88, which is 13% above median its 10-year median of 14.92 and 177.6% above the Medical Diagnostics & Research industry median of 6.08. Labcorp Holdings' overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current EV-to-OCF is 16.88 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued.
The current stock price of $296.35 is trading 9.6% above its estimated GF Value™ of $270.43.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LTS:0JSY:
EV-to-OCF: 16.88 (13% above median its 10-year median of 14.92)
GF Value™: $270.43 vs. price of $296.35 (9.6% above fair value)
Industry Position: 177.6% above the Medical Diagnostics & Research median (#150 of 213)
No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
80GF Score
Get the complete analysis for LTS:0JSY
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0JSY has been successfully added to your 
